Related Experiment Video

Updated: May 25, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Hyperglycemia in nondiabetic patients during the acute phase of stroke

Daniel Agustin Godoy1, Caridad Soler, Walter Videtta

  • 1Neurointensive Care Unit, Sanatorio Pasteur, Catamarca, Argentina. dagodoytorres@yahoo.com.ar

Arquivos De Neuro-Psiquiatria
|February 8, 2012
PubMed

Insights

Hyperglycemic (HG) control in acute stroke varies significantly among Latin-American neurocritical care physicians. Management strategies and glucose level definitions differ widely, indicating a need for standardized protocols in stroke care.

Area of Science:

  • Neurology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Hyperglycemia is a common complication in acute stroke.
  • Effective management of hyperglycemia is crucial for improving stroke outcomes.
  • Current practices in Latin America lack standardization.

Purpose of the Study:

  • To investigate the current patterns and variability in the management of hyperglycemia among Latin-American physicians specializing in neurocritical care.
  • To identify common practices and discrepancies in defining and treating elevated blood glucose levels in acute stroke patients.

Main Methods:

  • An anonymous online survey was distributed to Latin-American neurocritical care physicians.
  • The survey collected data on the definition of hyperglycemia, treatment preferences, monitoring methods, and adherence to protocols.
  • A response rate of 74% was achieved.

Main Results:

  • Significant variability was observed in the definition of hyperglycemia, with 50% of physicians considering levels >140 mg/dL.
  • Intravenous regular insulin was the preferred treatment, but only 23% utilized intensive insulin therapy (IIT).
  • Glucose monitoring frequency varied, with most physicians (56.7%) monitoring more than twice daily in the ICU, often using reactive strips for intensive monitoring.

Conclusions:

  • There is considerable variability and heterogeneity in the management of elevated blood glucose during the acute phase of stroke among surveyed Latin-American physicians.
  • The findings highlight a need for evidence-based guidelines and standardized protocols to optimize hyperglycemic control in acute stroke patients in this region.
Abstract

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...